Correlation Between Oncorus and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Oncorus and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Aerovate Therapeutics, you can compare the effects of market volatilities on Oncorus and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Aerovate Therapeutics.
Diversification Opportunities for Oncorus and Aerovate Therapeutics
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Oncorus and Aerovate is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Oncorus i.e., Oncorus and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Oncorus and Aerovate Therapeutics
Given the investment horizon of 90 days Oncorus is expected to under-perform the Aerovate Therapeutics. In addition to that, Oncorus is 4.36 times more volatile than Aerovate Therapeutics. It trades about -0.15 of its total potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.01 per unit of volatility. If you would invest 1,665 in Aerovate Therapeutics on August 31, 2024 and sell it today you would lose (1,402) from holding Aerovate Therapeutics or give up 84.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 2.94% |
| Values | Daily Returns |
Oncorus vs. Aerovate Therapeutics
Performance |
| Timeline |
| Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Aerovate Therapeutics |
Oncorus and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncorus and Aerovate Therapeutics
The main advantage of trading using opposite Oncorus and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
| Aerovate Therapeutics vs. Cue Biopharma | Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. Inhibrx | Aerovate Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |